BESSEMER GROUP INC - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 116 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2022$6,765,000
-46.1%
357,5770.0%0.01%
-44.0%
Q4 2021$12,544,000
-4.2%
357,5770.0%0.02%
-10.7%
Q3 2021$13,091,000
-6.8%
357,5770.0%0.03%
-6.7%
Q2 2021$14,042,000
+38.8%
357,577
-0.1%
0.03%
+25.0%
Q1 2021$10,115,000
+14.7%
358,028
+30.0%
0.02%
+4.3%
Q4 2020$8,817,000
-0.9%
275,3460.0%0.02%
-11.5%
Q3 2020$8,894,000275,3460.03%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Karst Peak Capital Ltd 1,349,185$43,430,00078.86%
AIA Investment Management Private Ltd 354,035$11,396,0002.43%
Bellevue Group AG 400,029$12,877,0000.82%
Prince Street Capital Management LLC 81,400$2,620,0000.55%
PRUDENTIAL PLC 4,247,748$136,735,0000.44%
OppenheimerFunds, Inc. 2,936,797$94,536,0000.11%
SECTORAL ASSET MANAGEMENT INC 31,628$1,018,0000.11%
Tibra Equities Europe Ltd 27,900$898,0000.11%
Jabre Capital Partners S.A. 10,000$322,0000.11%
SCHRODER INVESTMENT MANAGEMENT GROUP 1,803,955$58,069,0000.10%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders